Oregon Public Employees Retirement Fund’s Amphastar Pharmaceuticals AMPH Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$156K	Sell	7,742 -300	-4%	-$6.05K	﹤0.01%	1485
2026 Q1	$158K	Sell	8,042 -100	-1%	-$2.45K	﹤0.01%	1459
2025 Q4	$218K	Buy	8,142 +100	+1%	+$2.58K	﹤0.01%	1397
2025 Q3	$214K	Sell	8,042 -400	-5%	-$10.3K	﹤0.01%	1388
2025 Q2	$194K	Sell	8,442 -100	-1%	-$2.48K	﹤0.01%	1392
2025 Q1	$248K	Sell	8,542 -300	-3%	-$9.58K	﹤0.01%	1334
2024 Q4	$328K	Sell	8,842 -100	-1%	-$4.57K	0.01%	1284
2024 Q3	$434K	Sell	8,942 -300	-3%	-$13.2K	0.01%	1202
2024 Q2	$370K	Sell	9,242 -800	-8%	-$33.1K	0.01%	1223
2024 Q1	$441K	Sell	10,042 -900	-8%	-$46.5K	0.01%	1198
2023 Q4	$677K	Sell	10,942 -375	-3%	-$19.7K	0.01%	1088
2023 Q3	$520K	Sell	11,317 -400	-3%	-$21.8K	0.01%	1261
2023 Q2	$673K	Sell	11,717 -400	-3%	-$17.7K	0.01%	1186
2023 Q1	$454K	Sell	12,117 -430	-3%	-$14.1K	0.01%	1341
2022 Q4	$352K	Buy	12,547 +133	+1%	+$3.86K	﹤0.01%	1433
2022 Q3	$349K	Buy	12,414 +54	+0.4%	+$1.76K	0.01%	1400
2022 Q2	$430K	Sell	12,360 -1,400	-10%	-$50K	0.01%	1192
2022 Q1	$494K	Sell	13,760 -400	-3%	-$11.3K	0.01%	1412
2021 Q4	$330K	Sell	14,160 -600	-4%	-$12.3K	﹤0.01%	1417
2021 Q3	$281K	Sell	14,760 -100	-0.7%	-$1.96K	﹤0.01%	1463
2021 Q2	$300K	Hold	14,860	–	–	﹤0.01%	1458
2021 Q1	$272K	Buy	14,860 +300	+2%	+$5.58K	﹤0.01%	1486
2020 Q4	$293K	Sell	14,560 -230	-2%	-$4.48K	﹤0.01%	1414
2020 Q3	$277K	Buy	14,790 +1,000	+7%	+$20.1K	﹤0.01%	1326
2020 Q2	$310K	Hold	13,790	–	–	﹤0.01%	1285
2020 Q1	$205K	Hold	13,790	–	–	﹤0.01%	1330
2019 Q4	$266K	Hold	13,790	–	–	﹤0.01%	1403
2019 Q3	$273K	Buy	13,790 +200	+1%	+$4.17K	﹤0.01%	1450
2019 Q2	$287K	Buy	13,590 +200	+1%	+$4.18K	﹤0.01%	1447
2019 Q1	$274K	Buy	13,390 +242	+2%	+$5.42K	﹤0.01%	1443
2018 Q4	$262K	Buy	+13,148	New	+$259K	﹤0.01%	1439

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

LAM Group Lake Oswego, Oregon $201M AUM 22.35% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Oregon Public Employees Retirement Fund's AMPH Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund reduced its Amphastar Pharmaceuticals (AMPH) stake by 3.7% in Q2 2026, selling an estimated $6.05K and leaving 7,742 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #1485.

Oregon Public Employees Retirement Fund first reported a position in AMPH in Q4 2018 and has held it in 31 quarters since. The position peaked at $677K in Q4 2023. 82 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

Oregon Public Employees Retirement Fund held 7,742 shares of Amphastar Pharmaceuticals worth $156K as of Q2 2026.
Oregon Public Employees Retirement Fund sold 300 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $6.05K.
Amphastar Pharmaceuticals made up ﹤0.01% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #1485 holding.
Oregon Public Employees Retirement Fund first reported a position in Amphastar Pharmaceuticals in Q4 2018 and has held it in 31 quarters since.
Oregon Public Employees Retirement Fund's Amphastar Pharmaceuticals position peaked at $677K in Q4 2023.
82 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.